[Federal Register: January 4, 2005 (Volume 70, Number 2)]
[Notices]
[Page 357-362]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ja05-45]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Early Hearing Detection and Intervention (EHDI) Tracking,
Surveillance, and Integration
Announcement Type: New.
Funding Opportunity Number: RFA 05028.
Catalog of Federal Domestic Assistance Number: The Catalog of
Federal Domestic Assistance number is 93.283.
DATES:
Letter of Intent Deadline (LOI): February 3, 2005.
Application Deadline: March 7, 2005.
[[Page 358]]
I. Funding Opportunity Description
Authority: This program is authorized under section 317(k)(2)
and 317(C) of the Public Health Service Act, [42 U.S.C. sections
247b(k)(2) and 247b-4], as amended.
Purpose: Currently, all States and many territories have
established early hearing detection and intervention programs and 37
states, plus the District of Columbia and Puerto Rico, have passed
legislation related to universal newborn hearing screening. The purpose
of the program is to (1) develop or enhance a sustainable state-based
EHDI tracking and surveillance system capable of accurately
ascertaining the disposition of every occurrent birth for each step
throughout the EHDI process, and (2) integrate the EHDI system with
other State/territorial screening, tracking, and surveillance programs
that identify children with special health care needs. Data from the
integrated EHDI system will enable State/territories and the Directors
of Speech and Hearing Programs in State Health and Welfare Agencies
(DSHPSHWA) to report accurate data for Healthy People 2010 Objective
28-11, and to assess progress on the EHDI National Goals.
Measurable outcomes of the program will be in alignment with one or
more of the following performance goals for the National Center on
Birth Defects and Disabilities: Prevent birth defects and developmental
disabilities and improve the health and quality of life of Americans
with disabilities.
This announcement is only for non-research activities supported by
CDC/ATSDR. If research is proposed, the application will not be
reviewed. For the definition of research, please see the CDC Web site
at the following Internet address: http://www.cdc.gov/od/ads/opspoll1.htm
.
Activities: Awardee activities for this program are as follows:
Establish or improve a State/territorial population based
surveillance and data tracking system to minimize infants lost to
follow-up by monitoring the status and progress of every infant through
the three components of the EHDI process including the specific results
of screening, audiological diagnosis, enrollment in early intervention,
and those lost to follow-up at each stage in the process. EHDI programs
that include in-patient and out-patient screening must be able to
report specific results for both. The system must be able to accurately
ascertain the outcome for every occurrent birth. The applicant should
include a data flow chart describing how the disposition of every
occurrent birth will be reported.
Establish or improve methods (e.g., linkage/integration
with vital records and newborn dried bloodspot screening) to identify,
match, collect, and report standardized unduplicated individual
identifiable data (not estimated or only aggregate) on screening
results including child date of birth, infant gender, maternal race,
maternal ethnicity, and maternal education level, date of screen,
results (e.g. pass/refer), screening equipment type, and number of
families that refuse screening;
Develop or improve reporting systems that will ensure that
accurate tracking and surveillance of unduplicated individual
identifiable data (not estimated or only aggregate) are collected,
including data such as diagnosis (degree of hearing loss), intervention
service (start date and type of service), date of hearing aid fit, and
date of cochlear implant. This will necessitate information be obtained
from multiple sources, e.g. birthing hospitals, diagnostic centers,
audiologists, physicians (Medical Home), and intervention programs
(Part C Early Intervention). Secure authenticated role-based Web access
is encouraged;
Develop or improve reporting systems that will ensure that
unduplicated individual identifiable tracking and surveillance data
collected from multiple sources will be used to minimize infants lost
to follow-up (e.g. linkage/integration with immunization registries and
birth defect registries);
Develop or improve mechanisms to identify and collect
standardized data on unduplicated individual infants/children with late
onset or progressive hearing loss within the State/territory;
Outline an analytic plan to use State/territorial level
unduplicated individual identifiable (not estimated) EHDI data in order
to obtain outcome data such as: Number/percent of infants screened
(occurrent births), referred, evaluated, and enrolled in intervention
programs; unexpected clusters of infants with hearing loss in
particular regions at particular times; unexpected differences in EHDI
screening performance between key variables such as participating
birthing hospitals, racial ethnic sub-populations, gender and
geographic location (urban vs. rural); false positive rates; loss to
follow-up rates; developmental indicators such as language scores
(quotients), socio-emotional levels, achievement scores, and or
intelligence quotients;
Design or enhance the program so that it can be integrated
with other screening and tracking programs that identify unduplicated
individual children with special health care needs such as newborn
dried blood spot screening, birth defects registries, fetal alcohol
syndrome surveillance, and part C of the Individuals with Disabilities
Education Act (IDEA) [http://www.nectac.org];
Collaborate with other State/territorial programs such as
Maternal and Child Health (MCH) [http://www.mchb.hrsa.gov], part C of
IDEA, private service programs, and advocacy groups to build a
coordinated EHDI infrastructure;
Develop a quality assurance/improvement plan to monitor
the accuracy and quality of reportable data (e.g. independent chart
review);
Develop a carefully designed and well-planned evaluation
plan to monitor progress on activities and to assess the timeliness,
completeness, and success of the project (applicants are encouraged to
review the Morbidity and Mortality Weekly Report (MMWR) Recommendations
and Reports ``Updated Guidelines for Evaluating Public Health
Surveillance Systems'' July 27, 2001/50(RR13);1-35 available at http://www.cdc.gov/mmwr/PDF/RR/RR5013.pdf
and ``Framework for Program
Evaluation in Public Health'' September 17, 1999/48(RR11);1-40
available at http://www.cdc.gov/mmwr/PDF/RR/RR4811.pdf). The plan
should be based on a clear rationale relating the activities within the
cooperative agreement, project goals, and evaluation measures. Wherever
possible, the measurement of progress toward goals should focus on
health outcome indicators, rather than on intermediate measures such as
process or outputs;
Prepare and publish manuscript(s) which describe(s) and
document the tracking system, definitions, methodology, collaborative
relationships, data collection, findings, and recommendations across
sites. Peer-to-peer interaction and collaboration with participating
EHDI programs, public health informatics, and related communities of
practice is encouraged;
Collaborate and share information on effective mechanisms
for obtaining screening data with other State/territorial/tribal
recipients, the CDC, and other Federal and national agencies. The
decision on how to share information will be a collaboration among the
States and other parties.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC will provide technical assistance as requested by the States/
territories for this program as follows:
Assist in designing, developing, and evaluating
methodologies and
[[Page 359]]
approaches used in State/territorial-based data collection and analysis
of data across sites.
Facilitate collaborative efforts to compile and
disseminate program results through presentations and publications.
Assist and provide technical assistance to States/
territories on surveillance of systems including hospitals,
audiologists, early intervention programs.
Assist in analyzing surveillance data related to EHDI.
Assist in designing, developing, and evaluating plans to
improve the access of children with hearing loss to health services and
intervention programs.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities section above.
Fiscal Year Funds: 2005.
Approximate Total Funding: $4,800,000 (This amount is an estimate,
and is subject to availability of funds.)
Approximate Number of Awards: 32.
Approximate Average Award: $150,000 (This amount is for the first
12-month budget period, and includes both direct and indirect costs).
Floor of Award Range: None.
Ceiling of Award Range: $200,000 (This ceiling is for the first 12-
month budget period.)
Anticipated Award Date: July 1, 2005.
Budget Period Length: 12 months.
Project Period Length: Three years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted by governments and their agencies,
such as:
Federally recognized Indian tribal governments
Indian tribes
Indian tribal organizations
State and local governments or their Bona Fide Agents
(this includes the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, the Commonwealth of the Northern Marianna
Islands, American Samoa, Guam, the Federated States of Micronesia, the
Republic of the Marshall Islands, and the Republic of Palau)
A Bona Fide Agent is an agency/organization identified by the State
as eligible to submit an application under the State eligibility in
lieu of a State application. If you are applying as a bona fide agent
of a State or local government, you must provide a letter from the
State or local government as documentation of your status. Place this
documentation behind the first page of your application form.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding amount greater than the ceiling of the
award range, your application will be considered non-responsive, and
will not be entered into the review process. You will be notified that
your application did not meet the submission requirements.
In order to receive new funding, current CDC-EHDI awardees under PA
00076, 01048, 00355 that successfully compete under this Program
Announcement will have their existing budget/project periods end on
June 30, 2005, and need to submit a Financial Status Report (FSR)
within 90 days of this new end date. This FSR will be used to determine
the amount of unobligated funds which can be requested to be carried
over into the new budget period.
Special Requirements: If your application is incomplete or non-
responsive to the special requirements listed in this section, it will
not be entered into the review process. You will be notified that your
application did not meet submission requirements.
Late applications will be considered non-responsive. See
section ``IV.3. Submission Dates and Times'' for more information on
deadlines.
To be eligible, applicants must document that they:
Do not have an established State/territory centralized
EHDI surveillance and tracking program; or
Are in the beginning stages of establishing a centralized
EHDI tracking and surveillance program; or
Already have a program but would like to refine their
existing surveillance and tracking program to integrate it with other
newborn screening, tracking, and surveillance programs; and
Have previously been awarded a CDC Cooperative Agreement
for EHDI Tracking, Surveillance, and Integration (Program Announcements
00076, 01048, or 03055).
The applicant must include this documentation in the cover letter
of the application. If it is not included, then the application will be
determined as non-responsive and returned without review.
Additionally, States or territories that have been awarded
a previous CDC Cooperative Agreement for EHDI Tracking, Surveillance,
and Integration (Program Announcements 00076, 01048, or 03055) need to
document progress in developing an EHDI tracking and surveillance
system, including reporting data from the most recent birth year. Data
reports should include a flow chart with specific data accurately
describing the disposition of every occurrent birth for each step
throughout screening, evaluation, and intervention. The applicant
should include this documentation in the narrative portion
``Understanding of the Problem and Current Status'' of the application.
Note: Title 2 of the United States Code Section 1611 states that
an organization described in Section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
IV.1. Address to Request Application Package
To apply for this funding opportunity use application form CDC
1246. Application forms and instructions are available on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Letter of Intent (LOI): Your LOI must be written in the following
format:
Maximum number of pages: Two
Font size: 12-point unreduced
Single spaced
Paper size: 8.5 by 11 inches
Page margin size: One inch
Printed only on one side of page
Written in plain language, avoid jargon
Your LOI must contain the following information:
Program announcement number
Program title
Proposed project director
The name of the organization
Primary contact person's name
Mailing address
Telephone number and, if available, fax number and e-mail
address
[[Page 360]]
Application: Applications should include the following items, in
the following order:
(1) Cover Letter: A one page cover letter stating that the
applicant is applying and how the applicant fulfills eligibility
requirements. Additionally, if the applicant is not the State health
agency, the applicant must provide a letter from the appropriate State
health agency designating the applicant as a bona fide agent. This
information should be placed directly behind the cover letter of the
application.
(2) Table of Contents: A table of contents that provides page
numbers for the following sections should follow the abstract. All
pages must be numbered.
(3) Narrative: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
Maximum number of pages: 25 pages. If your narrative
exceeds the page limit, only the first pages which are within the page
limit will be reviewed.
Font size: 12 point unreduced
Double spaced
Paper size: 8.5 by 11 inches
Page margin size: One inch
Printed only on one side of page
Held together only by rubber bands or metal clips; not
bound in any other way.
Your narrative should provide a detailed description of first-year
activities and briefly describe future year objectives and activities.
It must include the following items in the order listed:
Understanding of the Problem and Current Status
Description of Proposed Program and Methodology
Goals and Objectives
Collaborative Efforts
Evaluation Plan
Staffing and Management System (One-page CV or resume for
all key personnel must be included in an attachment). Plan must also
provide details of the role of all key personnel.
Organizational Structure and Facilities (Must include an
organizational chart as an attachment)
(4) Budget and Budget Justification: The budget and budget
justification will not be counted toward the narrative page limit. The
budget should be reasonable, clearly justified, and consistent with the
intended use of the cooperative agreement funds. The applicant must
include a detailed first-year budget which indicates the anticipated
costs for personnel, fringe benefits, travel, supplies, contractual,
consultants, equipment, indirect, and other items with future annual
projections. Budgets should include travel funds for two project staff
per each grant year to participate in mandatory CDC sponsored regional
or annual meetings. The applicant should provide a budget justification
for each budget item. Proposed sub-contracts should identify the name
of the contractor, if known; describe the services to be performed;
provide an itemized budget and justification for the estimated costs of
the contract; specify the period of performance; and describe the
method of selection.
(5) Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes:
An organizational chart
Data flow chart
Time line Gant chart
One-page CV or resume for all key personnel
Letters of agreement and cooperation from collaborating
programs
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal Government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-
5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm
.
If your application form does not have a DUNS number field, please
write your DUNS number at the top of the first page of your
application, and/or include your DUNS number in your application cover
letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
LOI Deadline Date: February 3, 2005.
CDC requests that you send a LOI if you intend to apply for this
program. Although the LOI is not required, not binding, and does not
enter into the review of your subsequent application, the LOI will be
used to gauge the level of interest in this program, and to allow CDC
to plan the application review.
Application Deadline Date: March 7, 2005.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you submit your application by the United States Postal
Service or commercial delivery service, you must ensure that the
carrier will be able to guarantee delivery by the closing date and
time. If CDC receives your submission after closing due to: (1) Carrier
error, when the carrier accepted the package with a guarantee for
delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the submission as having
been received by the deadline.
This announcement is the definitive guide on LOI and application
content, submission address, and deadline. It supersedes information
provided in the application instructions. If your submission does not
meet the deadline above, it will not be eligible for review, and will
be discarded. You will be notified that you did not meet the submission
requirements.
CDC will not notify you upon receipt of your submission. If you
have a question about the receipt of your LOI or application, first
contact your courier. If you still have a question, contact the PGO-TIM
staff at: 770-488-2700. Before calling, please wait two to three days
after the submission deadline. This will allow time for submissions to
be processed and logged.
IV.4. Intergovernmental Review of Applications
Your application is subject to Intergovernmental Review of Federal
Programs, as governed by Executive Order (EO) 12372. This order sets up
a system for State and local governmental review of proposed Federal
assistance applications. You should contact your state single point of
contact (SPOC) as early as possible to alert the SPOC to prospective
applications, and to receive instructions on your state's process.
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds may not be used for research.
Reimbursement of pre-award costs is not allowed.
Award recipients agree to use cooperative agreement funds
for travel by project staff selected by CDC to participate in CDC-
sponsored
[[Page 361]]
workshops, or other called meetings such as regional or annual
meetings.
Funds may not be used to supplant other available
applicant or collaborating agency funds or to supplant State/territory
funds available for screening, diagnosis, intervention or tracking for
hearing loss or other disorders detected by newborn screening.
Funds may not be used for construction, for lease or
purchase of facilities or space, purchase of screening and diagnostic
equipment, or for patient care.
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement should be less than 12
months of age.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6. Other Submission Requirements
LOI Submission Address: Submit your LOI by express mail, delivery
service, fax, or E-mail to: John Eichwald, EHDI Team Lead, National
Center for Birth Defects and Developmental Disabilities (NCBDDD),
Centers for Disease Control and Prevention, 1600 Clifton Road, NE.,
Mailstop E-88, Atlanta, GA 30333; Telephone: 404-498-3961; E-mail
Address: jeichwald@cdc.gov.
Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:
Technical Information Management-05028, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
V.1. Criteria
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement. Measures of effectiveness must
relate to the performance goals stated in the ``Purpose'' section of
this announcement. Measures must be objective and quantitative, and
must measure the intended outcome. These measures of effectiveness must
be submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
1. Description of Program and Methodology (30 percent).
a. Extent to which applicant describes an effective and realistic
plan to address the challenges, barriers, and problems described in
section 4b ``Understanding the Problem and Current Status''
particularly those related to data requests that the EHDI program can
not presently provide (e.g. maternal race, maternal ethnicity, maternal
education level, results of in-patient and out-patient screening,
audiologic results, referrals to early intervention, etc.);
b. Extent to which applicant describes the methods they will use
establishing or improving methods to identify, match, collect, and
report standardized unduplicated individual identifiable data for every
occurrent birth;
c. Extent to which applicant describes the methods they will use
developing or improving reporting systems that ensure that accurate
tracking and surveillance of unduplicated individual identifiable
data--secure authenticated role-based Web access is encouraged;
d. Extent to which applicant describes the methods they will use
developing or improving reporting systems from multiple sources;
e. Extent to which applicant describes the methods they will use
developing or improving mechanisms to identify late onset or
progressive hearing loss;
f. Extent to which applicant describes the methods they will use
designing an analytic plan;
g. Extent to which applicant describes the methods they will use
preparing manuscripts.
2. Goals and Objectives (20 percent).
a. Extent to which applicant clearly describes the short- and long-
term goals and measurable objectives of the project;
b. Extent to which applicant's goals and objectives are realistic
and are consistent with the stated goals and purpose of this
announcement;
c. Extent to which applicant provides a time line which includes
activities to be accomplished and personnel responsible to complete the
project. The inclusion of a schedule plotting the tasks, people
responsible for these tasks, and a timeline (such as a Gant chart) is
encouraged and can be included as an attachment;
3. Collaborative Efforts (20 percent).
a. Extent to which applicant describes and documents their methods
for collaboration with multiple data sources (include written
assurances) such as hospitals, diagnostic centers, and intervention
service providers;
b. Extent to which collaborative relationships are documented which
will facilitate linkage with other screening, tracking, and
surveillance programs. Letters of agreement and cooperation from
collaborating programs should be included (such as vital records,
newborn dried bloodspot screening, immunization registries, birth
defect registries, and notifiable disease systems);
c. Extent to which collaborative efforts with other relevant
programs are documented (such as MCH, Early Intervention Part C, etc.);
d. Extent to which applicant describes their plans to work
collaboratively with other state/territorial/tribal recipients, the
CDC, and other federal and national agencies on effective mechanisms
for obtaining data on screening.
4. Understanding the Problem and Current Status (10 percent).
a. Extent to which the applicant has a clear, concise understanding
of the requirements and purpose of the cooperative agreement;
b. Extent to which the applicant understands the challenges,
barriers, and problems associated with developing and improving an EHDI
tracking and surveillance program including those with data collection;
c. Extent to which the applicant describes the need for funds to
develop/enhance an EHDI tracking and surveillance program in their
State or territory;
d. Extent to which the applicant describes the target population
and the current status of their existing EHDI program, i.e., accounting
for all occurrent infants born, including number of infants screened,
number of infants passing the screen, number of infants receiving
audiological diagnosis, number of infants identified with hearing loss
and number of infants receiving early intervention services;
e. Extent to which the applicant's data flow chart describes how
the disposition of every occurrent birth will be reported.
f. Extent to which applicant describes (1) their current EHDI
tracking and surveillance system (if any exists); (2) other relevant
tracking, surveillance systems, or registries in the State/Territory;
and (3) integration and linkages with other relevant systems;
5. Evaluation Plan (10 percent).
a. Extent to which applicant describes a plan for gathering
necessary information for improving and accounting for program
effectiveness;
b. Extent to which applicant describes an evaluation plan that will
monitor progress toward their goals, and assess timeliness,
completeness, and success of the objectives and activities of the
project;
c. Extent to which applicant describes a plan that monitors the
quality of the data being collected to include the
[[Page 362]]
development of a data quality improvement plan.
6. Staffing and Management System (5 percent).
a. Extent to which key personnel have skills and experience to
develop, implement or refine an EHDI tracking and surveillance system;
b. Extent of the managerial ability to coordinate the tracking,
surveillance, and integration components of the project;
c. Extent to which expertise in abstracting screening,
identification, and intervention records are demonstrated;
d. Extent to which expertise in epidemiologic methods, public
health surveillance, data management and computer programming is
demonstrated; and
e. Extent to which there is sufficient dedicated staff time to
develop, implement or refine an EHDI tracking and surveillance system
and to integrate the EHDI system with other newborn screening systems
(include percentage of time each staff member will contribute to the
project).
7. Organizational Structure and Facilities (5 percent)
Extent to which the organizational structure and the facilities/
space/equipment are adequate in carrying out the activities of the
program.
8. Budget (not scored).
The budget will be evaluated for the extent to which it is
reasonable, clearly justified, and consistent with the intended use of
the cooperative agreement funds. The applicant shall describe and
indicate the availability of facilities and equipment necessary to
carry out this project.
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by the National
Center on Birth Defects and Developmental Disabilities (NCBDDD).
Incomplete applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above. The objective review panel will consist of CDC employees
who will be randomly assigned applications to review and score.
Applications will be funded in order by score and rank determined by
the review panel. CDC will provide justification for any decision to
fund out of rank order.
V.3. Anticipated Announcement and Award Dates
[May 2005 for a] July 1, 2005, project start date.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-7 Executive Order 12372.
AR-9 Paperwork Reduction Act Requirements.
AR-10 Smoke-Free Workplace Requirements.
AR-11 Healthy People 2010.
AR-12 Lobbying Restrictions.
AR-24 Health Insurance Portability and Accountability Act
Requirements.
AR-25 Release and Sharing of Data.
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, due no less than 90 days before the end
of the budget period. The progress report will serve as your non-
competing continuation application, and must contain the following
elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Measures of Effectiveness.
f. Additional Requested Information.
2. Financial status report and annual progress report, no more than
90 days after the end of the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
We encourage inquiries concerning this announcement. For general
questions, contact: Technical Information Management Section, CDC
Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341;
Telephone: 770-488-2700.
For program technical assistance, contact: John Eichwald, EHDI Team
Lead, Centers for Disease Control and Prevention, 1600 Clifton Road,
NE., Mailstop E-88, Atlanta, GA 30333; Telephone: 404-498-3961; E-mail
Address: jeichwald@cdc.gov.
For financial, grants management, or budget assistance, contact:
Mildred Garner, Grants Management Specialist, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341; Telephone: 770-
488-2745; E-mail: MGarner@cdc.gov.
VIII. Other Information
This and other CDC funding opportunity announcements can be found
on the CDC Web site, Internet address: http://www.cdc.gov. Click on
``Funding'' then ``Grants and Cooperative Agreements.''
Dated: December 28, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-32 Filed 1-3-05; 8:45 am]
BILLING CODE 4163-18-P